Nownews生活新聞: 新藥延命！雙標靶＋化療 晚期乳癌7成存活逾5年

Nownews生活新聞 www.nownews.com

Ever want to impress your boss or that special someone? Learn the basics of wine tasting from glassware to history to tasting techniques in this online course. This is a course you're sure to enjoy! From our sponsors

新藥延命！雙標靶＋化療　晚期乳癌7成存活逾5年 Oct 2nd 2013, 03:45 〔記者陳鈞凱╱台北報導〕乳癌是台灣女性健康的頭號殺手，每年更有超過2000多名新增病患屬於棘手的HER2陽性、轉移性乳癌，現在治療有新突破，醫師表示，今年7月最新的乳癌標靶藥物已在台核准上市，透過「雙標靶＋化療」模式，可多增加病患存活時間半年以上，即使癌細胞已轉移，人體實驗也證實，仍有7成病患可存活超過5年。

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions